1. Tregoning, J.S., R.F. Russell, and E. Kinnear, Adjuvanted influenza vaccines. Hum Vaccin Immunother, 2018. 14(3): p. 550-564.
2. Palache, A., et al., Seasonal influenza vaccine dose distribution in 157 countries (2004-2011). Vaccine, 2014. 32(48): p. 6369-76.
3. Behzadi, M.A. and V.H. Leyva-Grado, Overview of Current Therapeutics and Novel Candidates Against Influenza, Respiratory Syncytial Virus, and Middle East Respiratory Syndrome Coronavirus Infections. Front Microbiol, 2019. 10: p. 1327.
4. Zhang, Y., et al., Targeting Hemagglutinin: Approaches for Broad Protection against the Influenza A Virus. Viruses, 2019. 11(5).
5. Jia, W., et al., A Novel Antigenic Drift of Avian Influenza A(H7N9) Virus in Poultry, China, 2018. J Infect Dis, 2019.
6. Jain, S., et al., Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009. N Engl J Med, 2009. 361(20): p. 1935-44.
7. Smith, G.J., et al., Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic. Nature, 2009. 459(7250): p. 1122-5.
8. Chiu, S.S., et al., Age-matched comparison of children hospitalized for 2009 pandemic H1N1 influenza with those hospitalized for seasonal H1N1 and H3N2. PLoS One, 2011. 6(7): p. e21837.
9. Writing Committee of the, W.H.O.C.o.C.A.o.P.I., et al., Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection. N Engl J Med, 2010. 362(18): p. 1708-19.
10. Su, S., et al., Epidemiology, Evolution, and Pathogenesis of H7N9 Influenza Viruses in Five Epidemic Waves since 2013 in China. Trends Microbiol, 2017. 25(9): p. 713-728.
11. Zhu, H., et al., Emergence and development of H7N9 influenza viruses in China. Curr Opin Virol, 2016. 16: p. 106-113.
12. Generous, A., et al., Identification of putative interactions between swine and human influenza A virus nucleoprotein and human host proteins. Virol J, 2014. 11: p. 228.
13. Enkirch, T., et al., Identification and in vivo Efficacy Assessment of Approved Orally Bioavailable Human Host Protein-Targeting Drugs With Broad Anti-influenza A Activity. Front Immunol, 2019. 10: p. 1097.
14. Ison, M.G., Antiviral Treatments. Clin Chest Med, 2017. 38(1): p. 139-153.
15. Doll, M.K., et al., Safety and effectiveness of neuraminidase inhibitors for influenza treatment, prophylaxis, and outbreak control: a systematic review of systematic reviews and/or meta-analyses. J Antimicrob Chemother, 2017. 72(11): p. 2990-3007.
16. Deyde, V.M., et al., Surveillance of resistance to adamantanes among influenza A(H3N2) and A(H1N1) viruses isolated worldwide. J Infect Dis, 2007. 196(2): p. 249-57.
17. Gubareva, L.V., et al., Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2015-2016. Antiviral Res, 2017. 146: p. 12-20.
18. de Chassey, B., et al., Virus-host interactomics: new insights and opportunities for antiviral drug discovery. Genome Med, 2014. 6(11): p. 115.
19. Karlas, A., et al., Genome-wide RNAi screen identifies human host factors crucial for influenza virus replication. Nature, 2010. 463(7282): p. 818-22.
20. Ackerman, E.E., et al., Network-Guided Discovery of Influenza Virus Replication Host Factors. MBio, 2018. 9(6).
21. Dai, X., L. Zhang, and T. Hong, Host cellular signaling induced by influenza virus. Sci China Life Sci, 2011. 54(1): p. 68-74.
22. Zhao, M., L. Wang, and S. Li, Influenza A Virus-Host Protein Interactions Control Viral Pathogenesis. Int J Mol Sci, 2017. 18(8).
23. Fujioka, Y., et al., A Ca(2+)-dependent signalling circuit regulates influenza A virus internalization and infection. Nat Commun, 2013. 4: p. 2763.
24. Fujioka, Y., et al., A Sialylated Voltage-Dependent Ca(2+) Channel Binds Hemagglutinin and Mediates Influenza A Virus Entry into Mammalian Cells. Cell Host Microbe, 2018. 23(6): p. 809-818 e5.
25. Wang, Q., et al., [Anti-inflammatory mechanism of heat-clearing and detoxifying Chinese herbs]. Zhongguo Zhong Yao Za Zhi, 2018. 43(18): p. 3787-3794.
26. Oliveira, H., et al., Gastrointestinal absorption, antiproliferative and anti-inflammatory effect of the major carotenoids of Gardenia jasminoides Ellis on cancer cells. Food Funct, 2017. 8(4): p. 1672-1679.
27. Lee, E.J., J.K. Hong, and W.K. Whang, Simultaneous determination of bioactive marker compounds from Gardeniae fructus by high performance liquid chromatography. Arch Pharm Res, 2014. 37(8): p. 992-1000.
28. Li, C., et al., Geniposide protects against hypoxia/reperfusion-induced blood-brain barrier impairment by increasing tight junction protein expression and decreasing inflammation, oxidative stress, and apoptosis in an in vitro system. Eur J Pharmacol, 2019. 854: p. 224-231.
29. Rong, Y.P., et al., Protective Effects of Geniposide on Hepatic Ischemia/Reperfusion Injury. Transplant Proc, 2017. 49(6): p. 1455-1460.
30. Zhou, Y.X., et al., Diverse Pharmacological Activities and Potential Medicinal Benefits of Geniposide. Evid Based Complement Alternat Med, 2019. 2019: p. 4925682.
31. Li, N., et al., Antioxidative Property and Molecular Mechanisms Underlying Geniposide-Mediated Therapeutic Effects in Diabetes Mellitus and Cardiovascular Disease. Oxid Med Cell Longev, 2019. 2019: p. 7480512.
32. Zhang, X., T. Gao, and Y. Wang, Geniposide alleviates lipopolysaccharide (LPS)-induced inflammation by downregulation of miR-27a in rat pancreatic acinar cell AR42J. Biol Chem, 2019.
33. Zhang, Z., et al., Geniposide-mediated protection against amyloid deposition and behavioral impairment correlates with downregulation of mTOR signaling and enhanced autophagy in a mouse model of Alzheimer's disease. Aging (Albany NY), 2019. 11(2): p. 536-548.
34. Zhang, H.Y., et al., Antithrombotic activities of aqueous extract from Gardenia jasminoides and its main constituent. Pharm Biol, 2013. 51(2): p. 221-5.
35. Zhang, Y., et al., Geniposide demonstrates anti-inflammatory and antiviral activity against pandemic A/Jiangsu/1/2009 (H1N1) influenza virus infection in vitro and in vivo. Antivir Ther, 2017. 22(7): p. 599-611.
36. Lin, Y.J., et al., Inhibition of enterovirus 71 infections and viral IRES activity by Fructus gardeniae and geniposide. Eur J Med Chem, 2013. 62: p. 206-13.
37. Son, M., et al., Genipin as a novel chemical activator of EBV lytic cycle. J Microbiol, 2015. 53(2): p. 155-65.
38. Guo, S., et al., The inhibitory effect of iridoid glycoside extracted from Fructus Gardeniae on intracellular acidification and extracellular Ca2+ influx induced by influenza A virus. Exp Biol Med (Maywood), 2014. 239(8): p. 986-997.
39. Spackman, E. and M.L. Killian, Avian influenza virus isolation, propagation, and titration in embryonated chicken eggs. Methods Mol Biol, 2014. 1161: p. 125-40.
40. Spackman, E., et al., Assessment of replicate numbers for titrating avian influenza virus using dose-response models. J Vet Diagn Invest, 2019. 31(4): p. 616-619.
41. Wang, Z., et al., [Establishment of drug screening assay and pharmacodynamic evaluation method targeting influenza RNA polymerase]. Yao Xue Xue Bao, 2012. 47(9): p. 1159-63.
42. Goldhill, D.H., et al., The mechanism of resistance to favipiravir in influenza. Proc Natl Acad Sci U S A, 2018. 115(45): p. 11613-11618.
43. Meliopoulos, V.A., et al., MicroRNA regulation of human protease genes essential for influenza virus replication. PLoS One, 2012. 7(5): p. e37169.
44. Watanabe, T., et al., Influenza virus-host interactome screen as a platform for antiviral drug development. Cell Host Microbe, 2014. 16(6): p. 795-805.
45. Han, J., et al., Genome-wide CRISPR/Cas9 Screen Identifies Host Factors Essential for Influenza Virus Replication. Cell Rep, 2018. 23(2): p. 596-607.
46. Jin, Y.H., et al., Ethanolic Extract of Melia Fructus Has Anti-influenza A Virus Activity by Affecting Viral Entry and Viral RNA Polymerase. Front Microbiol, 2017. 8: p. 476.
47. Li, X., et al., U13 --> C13 mutation in the variable region of the NA gene 3'UTR of H9N2 influenza virus influences the replication and transcription of NA and enhances virus infectivity. Virus Genes, 2019. 55(4): p. 440-447.
48. Chen, J.Y., et al., Anti-inflammatory effects and pharmacokinetics study of geniposide on rats with adjuvant arthritis. Int Immunopharmacol, 2015. 24(1): p. 102-9.
49. Dai, M.M., et al., Effects and mechanisms of Geniposide on rats with adjuvant arthritis. Int Immunopharmacol, 2014. 20(1): p. 46-53.
50. Chen, Y., et al., Neuroprotective effects of geniposide in the MPTP mouse model of Parkinson's disease. Eur J Pharmacol, 2015. 768: p. 21-7.
51. J.Wurzer, W., et al., Caspase 3 activation is essential for efficient
in ̄uenza virus propagation. 2003.
52. Jiang, Y.Q., et al., Geniposide Prevents Hypoxia/Reoxygenation-Induced Apoptosis in H9c2 Cells: Improvement of Mitochondrial Dysfunction and Activation of GLP-1R and the PI3K/AKT Signaling Pathway. Cell Physiol Biochem, 2016. 39(1): p. 407-21.
53. Mehrbod, P., et al., The roles of apoptosis, autophagy and unfolded protein response in arbovirus, influenza virus, and HIV infections. Virulence, 2019. 10(1): p. 376-413.
54. Wu, X., et al., A Hybrid Perturbative-Stochastic Galerkin Method for the Variability Analysis of Nonuniform Transmission Lines. IEEE Transactions on Electromagnetic Compatibility, 2020. 62(3): p. 746-754.
55. Dong, C., R.J. Davis, and R.A. Flavell, MAP kinases in the immune response. Annu Rev Immunol, 2002. 20: p. 55-72.
56. Chiaretti, A., et al., Interleukin and neurotrophin up-regulation correlates with severity of H1N1 infection in children: a case-control study. Int J Infect Dis, 2013. 17(12): p. e1186-93.
57. Lu, Q., et al., Molecular Characterization and Biological Function of a Novel LncRNA CRNG in Swine. Front Pharmacol, 2019. 10: p. 539.
58. Nguyen, T.T.H., et al., Inhibition effect of flavonoid compounds against neuraminidase expressed in Pichia pastoris. Biotechnol Bioprocess Eng, 2014. 19(1): p. 70-75.
59. Wang, X.B., et al., Regulation of surface and intracellular expression of CTLA-4 on human peripheral T cells. Scand J Immunol, 2001. 54(5): p. 453-8.
60. Ayukawa, H., et al., Expression of CTLA-4 (CD152) in peripheral blood T cells of children with influenza virus infection including encephalopathy in comparison with respiratory syncytial virus infection. Clin Exp Immunol, 2004. 137(1): p. 151-5.
61. Crabtree, J.N., et al., Autoimmune Variant PTPN22 C1858T Is Associated With Impaired Responses to Influenza Vaccination. J Infect Dis, 2016. 214(2): p. 248-57.
62. Hasegawa, K., et al., PEST domain-enriched tyrosine phosphatase (PEP) regulation of effector/memory T cells. Science, 2004. 303(5658): p. 685-9.
63. Nichols, J.E., J.A. Niles, and N.J. Roberts, Jr., Human lymphocyte apoptosis after exposure to influenza A virus. J Virol, 2001. 75(13): p. 5921-9.
64. Ehrhardt, C., et al., Influenza A virus NS1 protein activates the PI3K/Akt pathway to mediate antiapoptotic signaling responses. J Virol, 2007. 81(7): p. 3058-67.
65. Shin, Y.K., et al., Influenza A virus NS1 protein activates the phosphatidylinositol 3-kinase (PI3K)/Akt pathway by direct interaction with the p85 subunit of PI3K. J Gen Virol, 2007. 88(Pt 1): p. 13-18.
66. Ludwig, S., et al., Influenza virus-induced AP-1-dependent gene expression requires activation of the JNK signaling pathway. J Biol Chem, 2001. 276(14): p. 10990-8.
67. Momose, F., et al., Cellular splicing factor RAF-2p48/NPI-5/BAT1/UAP56 interacts with the influenza virus nucleoprotein and enhances viral RNA synthesis. J Virol, 2001. 75(4): p. 1899-908.
68. Pizzorno, A., et al., Repurposing of Drugs as Novel Influenza Inhibitors From Clinical Gene Expression Infection Signatures. Front Immunol, 2019. 10: p. 60.
69. Colomer, J. and A.R. Means, Physiological roles of the Ca2+/CaM-dependent protein kinase cascade in health and disease. Subcell Biochem, 2007. 45: p. 169-214.
70. Andrews, C.S., et al., Nontypeable Haemophilus influenzae-Induced MyD88 Short Expression Is Regulated by Positive IKKβ and CREB Pathways and Negative ERK1/2 Pathway. PLoS One, 2015. 10(12): p. e0144840.
71. Moreno, J.L., et al., Maternal influenza viral infection causes schizophrenia-like alterations of 5-HT₂A and mGlu₂ receptors in the adult offspring. J Neurosci, 2011. 31(5): p. 1863-72.
72. Peng, N., et al., Inducible Major Vault Protein Plays a Pivotal Role in Double-Stranded RNA- or Virus-Induced Proinflammatory Response. J Immunol, 2016. 196(6): p. 2753-66.